Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.
Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.
New Clues to Link Between MS Drug Tysabri and Rare Brain Disease
Quantitative assessment of upper limb motor function in Multiple Sclerosis using an instrumented Action Research Arm Test.
Multiple sclerosis: Clinical characteristics and disability progression in Moroccan children.
Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
Atypical Optic Neuritis.
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Efficient in vivo depletion of CD8(+) T lymphocytes in common marmosets by novel CD8 monoclonal antibody administration.
A novel approach for reliable detection of cathepsin S activities in mouse antigen presenting cells.
Cortical remyelination: A new target for repair therapies in multiple sclerosis.
MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms.
International Pediatric MS Study Group Clinical Trials Summit: Meeting report.
Multiple sclerosis presenting as a relapsing amnestic syndrome.
The co-occurrence of pain and depression in adults with multiple sclerosis.
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
Complex assessment in progressive multiple sclerosis: a case report.
Bipolar disorder and multiple sclerosis: a case series.
Relationship between contrast sensitivity test and disease severity in multiple sclerosis patients.
Development of a cell-based assay for the detection of anti-aquaporin 1 antibodies in neuromyelitis optica spectrum disorders.
Features of sleep disturbances in multiple sclerosis patients.
Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients.
IL-17: A new actor in IFN-driven systemic autoimmune diseases.
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Multiple sclerosis: Efficacy of fingolimod confirmed on all MRI end points.

Pages